BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu G, Bi Y, Shen B, Yang H, Zhang Y, Wang X, Liu H, Lu Y, Liao J, Chen X, Chu Y. SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis. Cancer Res 2014;74:727-37. [PMID: 24351289 DOI: 10.1158/0008-5472.CAN-13-2584] [Cited by in Crossref: 118] [Cited by in F6Publishing: 126] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 He J, Huo F, Tang H, Liu B, Bu L. Myeloid-derived suppressor cells in head and neck squamous cell carcinoma. International Review of Cell and Molecular Biology 2023. [DOI: 10.1016/bs.ircmb.2022.11.002] [Reference Citation Analysis]
2 Zhang W, Lyu P, Andreev D, Jia Y, Zhang F, Bozec A. Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma. Front Cell Dev Biol 2022;10:974851. [PMID: 36578780 DOI: 10.3389/fcell.2022.974851] [Reference Citation Analysis]
3 Zhao X, Zhao R, Wen J, Zhang X, Wu S, Fang J, Ma J, Zheng W, Zhang X, Lu Z, Gao L, Hu Y. Anlotinib reduces the suppressive capacity of monocytic myeloid-derived suppressor cells and potentiates the immune microenvironment normalization window in a mouse lung cancer model. Anti-Cancer Drugs 2022;Publish Ahead of Print. [DOI: 10.1097/cad.0000000000001481] [Reference Citation Analysis]
4 Harris B, Saleem S, Cook N, Searle E. Targeting hypoxia in solid and haematological malignancies. J Exp Clin Cancer Res 2022;41:318. [PMID: 36320041 DOI: 10.1186/s13046-022-02522-y] [Reference Citation Analysis]
5 Tumino N, Fiore PF, Pelosi A, Moretta L, Vacca P. Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells. Semin Immunol 2022;61-64:101668. [PMID: 36370673 DOI: 10.1016/j.smim.2022.101668] [Reference Citation Analysis]
6 Dong L, Cao Y, Yang H, Hou Y, He Y, Wang Y, Yang Q, Bi Y, Liu G. The hippo kinase MST1 negatively regulates the differentiation of follicular helper T cells. Immunology 2022. [DOI: 10.1111/imm.13590] [Reference Citation Analysis]
7 Geranmayeh MH, Rahbarghazi R, Saeedi N, Farhoudi M. Metformin-dependent variation of microglia phenotype dictates pericytes maturation under oxygen-glucose deprivation. Tissue Barriers 2022;10:2018928. [PMID: 34983297 DOI: 10.1080/21688370.2021.2018928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 De Sanctis F, Adamo A, Canè S, Ugel S. Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy. Semin Immunopathol 2022. [PMID: 36161514 DOI: 10.1007/s00281-022-00965-1] [Reference Citation Analysis]
9 van Geffen C, Heiss C, Deißler A, Kolahian S. Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation. Front Immunol 2022;13:933847. [DOI: 10.3389/fimmu.2022.933847] [Reference Citation Analysis]
10 Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther 2022;7:258. [PMID: 35906199 DOI: 10.1038/s41392-022-01102-y] [Reference Citation Analysis]
11 Li Q, Xiang M. Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy. Acta Pharmacol Sin 2022;43:1337-48. [PMID: 34561553 DOI: 10.1038/s41401-021-00776-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mukherjee S, Ghosh S, Sengupta A, Sarkar S, Keswani T, Chatterjee R, Bhattacharyya A. IL-6 dependent expansion of inflammatory MDSCs (CD11b+ Gr-1+) promote Th-17 mediated immune response during experimental cerebral malaria. Cytokine 2022;155:155910. [PMID: 35594680 DOI: 10.1016/j.cyto.2022.155910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Munansangu BSM, Kenyon C, Walzl G, Loxton AG, Kotze LA, du Plessis N. Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology. Int J Mol Sci 2022;23:3512. [PMID: 35408873 DOI: 10.3390/ijms23073512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li Y, Jia A, Yang H, Wang Y, Wang Y, Yang Q, Cao Y, Bi Y, Liu G. Protein Tyrosine Phosphatase PTPRO Signaling Couples Metabolic States to Control the Development of Granulocyte Progenitor Cells. J I 2022;208:1434-1444. [DOI: 10.4049/jimmunol.2100878] [Reference Citation Analysis]
15 Bayik D, Lee J, Lathia JD. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis. Exp Suppl 2022;113:189-217. [PMID: 35165865 DOI: 10.1007/978-3-030-91311-3_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mirzaei R, Sabokroo N, Ahmadyousefi Y, Motamedi H, Karampoor S. Immunometabolism in biofilm infection: lessons from cancer. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00435-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Li J, Bolyard C, Xin G, Li Z. Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy. Front Cell Dev Biol 2021;9:747863. [PMID: 34988072 DOI: 10.3389/fcell.2021.747863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zheng Z, Bian C, Wang H, Su J, Meng L, Xin Y, Jiang X. Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer. Ther Adv Med Oncol 2022;14:175883592211383. [DOI: 10.1177/17588359221138383] [Reference Citation Analysis]
19 Rathod S, Aggarwal V, Upadhyay A, Choudhari R. Timing of the Major Metabolic Switches in Immune Cell Activation and Differentiation During Cancer Development. Immuno-Oncology Crosstalk and Metabolism 2022. [DOI: 10.1007/978-981-16-6226-3_7] [Reference Citation Analysis]
20 Balahura L, Lazar A, Dinescu S, Costache M. Tumor Microenvironment Complexity: A Pathological Milieu that Innately Modulates Cancer Progression. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_89-1] [Reference Citation Analysis]
21 Dai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer 2021;20. [DOI: 10.1186/s12943-021-01464-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
22 Fortuny L, Sebastián C. Sirtuins as Metabolic Regulators of Immune Cells Phenotype and Function. Genes (Basel) 2021;12:1698. [PMID: 34828304 DOI: 10.3390/genes12111698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mehrabi M, Amini F, Mehrabi S. Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages. Front Oncol 2021;11:693076. [PMID: 34557407 DOI: 10.3389/fonc.2021.693076] [Reference Citation Analysis]
24 Li Y, He H, Jihu R, Zhou J, Zeng R, Yan H. Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment. Front Cell Dev Biol 2021;9:698532. [PMID: 34527668 DOI: 10.3389/fcell.2021.698532] [Reference Citation Analysis]
25 Garcia-Peterson LM, Li X. Trending topics of SIRT1 in tumorigenicity. Biochim Biophys Acta Gen Subj 2021;1865:129952. [PMID: 34147543 DOI: 10.1016/j.bbagen.2021.129952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
26 Gao L, Gong FZ, Ma LY, Yang JH. Uncarboxylated osteocalcin promotes osteogenesis and inhibits adipogenesis of mouse bone marrow-derived mesenchymal stem cells via the PKA-AMPK-SIRT1 axis. Exp Ther Med 2021;22:880. [PMID: 34194558 DOI: 10.3892/etm.2021.10312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Jiang Y, Li L, Li Y, Liu G, Hoffman RM, Jia L. Neddylation Regulates Macrophages and Implications for Cancer Therapy. Front Cell Dev Biol 2021;9:681186. [PMID: 34164400 DOI: 10.3389/fcell.2021.681186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Li X, Li Y, Yu Q, Qian P, Huang H, Lin Y. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges. J Leukoc Biol 2021;110:257-70. [PMID: 34075637 DOI: 10.1002/JLB.1MR0421-597RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Qiu Y, Zhou X, Liu Y, Tan S, Li Y. The Role of Sirtuin-1 in Immune Response and Systemic Lupus Erythematosus. Front Immunol 2021;12:632383. [PMID: 33981300 DOI: 10.3389/fimmu.2021.632383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
30 Moshfegh CM, Case AJ. The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension. Antioxid Redox Signal 2021;34:915-35. [PMID: 32237890 DOI: 10.1089/ars.2020.8042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Zhang M, Lu P, Terada T, Sui M, Furuta H, Iida K, Katayama Y, Lu Y, Okamoto K, Suzuki M, Asakura T, Shimizu K, Hakuno F, Takahashi SI, Shimada N, Yang J, Ishikawa T, Tatsuzaki J, Nagata K. Quercetin 3,5,7,3',4'-pentamethyl ether from Kaempferia parviflora directly and effectively activates human SIRT1. Commun Biol 2021;4:209. [PMID: 33608631 DOI: 10.1038/s42003-021-01705-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
32 Yin Q, Shen L, Qi Y, Song D, Ye L, Peng Y, Wang Y, Jin Z, Ning G, Wang W, Lin D, Wang S. Decreased SIRT1 expression in the peripheral blood of patients with Graves' disease. J Endocrinol 2020;246:161-73. [PMID: 32485674 DOI: 10.1530/JOE-19-0501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M, Salehi R, Sadeghi B, Manian M. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int 2021;21:62. [PMID: 33472628 DOI: 10.1186/s12935-020-01719-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 95] [Article Influence: 40.0] [Reference Citation Analysis]
34 Khan AA, Liu X, Yan X, Tahir M, Ali S, Huang H. An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression. Cancer Metastasis Rev. 2021;40:245-272. [PMID: 33423164 DOI: 10.1007/s10555-020-09952-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
35 Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol 2021;21:485-98. [PMID: 33526920 DOI: 10.1038/s41577-020-00490-y] [Cited by in Crossref: 380] [Cited by in F6Publishing: 373] [Article Influence: 190.0] [Reference Citation Analysis]
36 Dong Z, Cui H. Sirtuins and cellular metabolism in cancers. Sirtuin Biology in Cancer and Metabolic Disease 2021. [DOI: 10.1016/b978-0-12-822467-0.00008-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Yu H. Sirtuins in immunometabolism. Sirtuin Biology in Cancer and Metabolic Disease 2021. [DOI: 10.1016/b978-0-12-822467-0.00010-3] [Reference Citation Analysis]
38 Anderson G. Tumour Microenvironment: Roles of the Aryl Hydrocarbon Receptor, O-GlcNAcylation, Acetyl-CoA and Melatonergic Pathway in Regulating Dynamic Metabolic Interactions across Cell Types-Tumour Microenvironment and Metabolism. Int J Mol Sci 2020;22:E141. [PMID: 33375613 DOI: 10.3390/ijms22010141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
39 Strauss L, Guarneri V, Gennari A, Sica A. Implications of metabolism-driven myeloid dysfunctions in cancer therapy. Cell Mol Immunol 2021;18:829-41. [PMID: 33077904 DOI: 10.1038/s41423-020-00556-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
40 Dai H, Xu H, Wang S, Ma J. Connections between Metabolism and Epigenetic Modification in MDSCs. Int J Mol Sci 2020;21:E7356. [PMID: 33027968 DOI: 10.3390/ijms21197356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
41 Li G, Tian Y, Zhu WG. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy. Front Cell Dev Biol 2020;8:576946. [PMID: 33117804 DOI: 10.3389/fcell.2020.576946] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 15.0] [Reference Citation Analysis]
42 Wang Y, Jia A, Bi Y, Wang Y, Yang Q, Cao Y, Li Y, Liu G. Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy. Cancers (Basel) 2020;12:E2626. [PMID: 32942545 DOI: 10.3390/cancers12092626] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
43 Kramer ED, Abrams SI. Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity. Front Immunol 2020;11:1963. [PMID: 32983128 DOI: 10.3389/fimmu.2020.01963] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
44 Corrado C, Fontana S. Hypoxia and HIF Signaling: One Axis with Divergent Effects. Int J Mol Sci 2020;21:E5611. [PMID: 32764403 DOI: 10.3390/ijms21165611] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 16.7] [Reference Citation Analysis]
45 Pan X, Zheng L. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment. Cell Mol Immunol 2020;17:940-53. [PMID: 32699350 DOI: 10.1038/s41423-020-0505-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
46 Yang Y, Li C, Liu T, Dai X, Bazhin AV. Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Front Immunol 2020;11:1371. [PMID: 32793192 DOI: 10.3389/fimmu.2020.01371] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 23.7] [Reference Citation Analysis]
47 Xue F, Yu M, Li L, Zhang W, Ma Y, Dong L, Shan W, Zheng Y, Wang T, Feng D, Lv J, Wang X. Elevated granulocytic myeloid-derived suppressor cells are closely related with elevation of Th17 cells in mice with experimental asthma. Int J Biol Sci 2020;16:2072-83. [PMID: 32549755 DOI: 10.7150/ijbs.43596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
48 Zhang Z, Dong L, Jia A, Chen X, Yang Q, Wang Y, Wang Y, Liu R, Cao Y, He Y, Bi Y, Liu G. Glucocorticoids Promote the Onset of Acute Experimental Colitis and Cancer by Upregulating mTOR Signaling in Intestinal Epithelial Cells. Cancers (Basel) 2020;12:E945. [PMID: 32290362 DOI: 10.3390/cancers12040945] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
49 He W, Xu J, Mu R, Li Q, Lv DL, Huang Z, Zhang J, Wang C, Dong L. High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation. Nat Commun 2020;11:1732. [PMID: 32265505 DOI: 10.1038/s41467-020-15524-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
50 Law AMK, Valdes-Mora F, Gallego-Ortega D. Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer. Cells 2020;9:E561. [PMID: 32121014 DOI: 10.3390/cells9030561] [Cited by in Crossref: 156] [Cited by in F6Publishing: 166] [Article Influence: 52.0] [Reference Citation Analysis]
51 Li KY, Yuan JL, Trafton D, Wang JX, Niu N, Yuan CH, Liu XB, Zheng L. Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects. Chronic Dis Transl Med 2020;6:6-17. [PMID: 32226930 DOI: 10.1016/j.cdtm.2020.01.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
52 Zheng N, Lu Y. Targeting the IL-9 pathway in cancer immunotherapy. Hum Vaccin Immunother 2020;16:2333-40. [PMID: 32040369 DOI: 10.1080/21645515.2019.1710413] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
53 Yang Z, Guo J, Weng L, Tang W, Jin S, Ma W. Myeloid-derived suppressor cells-new and exciting players in lung cancer. J Hematol Oncol 2020;13:10. [PMID: 32005273 DOI: 10.1186/s13045-020-0843-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 18.0] [Reference Citation Analysis]
54 Hu C, Pang B, Lin G, Zhen Y, Yi H. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells. Br J Cancer 2020;122:23-9. [PMID: 31819182 DOI: 10.1038/s41416-019-0644-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
55 Dong L, He Y, Zhou S, Cao Y, Li Y, Bi Y, Liu G. HIF1α-Dependent Metabolic Signals Control the Differentiation of Follicular Helper T Cells. Cells 2019;8:E1450. [PMID: 31744227 DOI: 10.3390/cells8111450] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
56 Ren MT, Gu ML, Zhou XX, Yu MS, Pan HH, Ji F, Ding CY. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis. World J Gastroenterol 2019; 25(38): 5800-5813 [PMID: 31636473 DOI: 10.3748/wjg.v25.i38.5800] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
57 Ramteke P, Deb A, Shepal V, Bhat MK. Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality. Cancers (Basel) 2019;11:E1402. [PMID: 31546918 DOI: 10.3390/cancers11091402] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 11.5] [Reference Citation Analysis]
58 Audrito V, Managò A, Gaudino F, Sorci L, Messana VG, Raffaelli N, Deaglio S. NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer. Front Immunol 2019;10:1720. [PMID: 31402913 DOI: 10.3389/fimmu.2019.01720] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
59 Stallone G, Infante B, Prisciandaro C, Grandaliano G. mTOR and Aging: An Old Fashioned Dress. Int J Mol Sci 2019;20:E2774. [PMID: 31174250 DOI: 10.3390/ijms20112774] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
60 Pandey V, Storz P. Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma. Expert Rev Anticancer Ther 2019;19:473-82. [PMID: 31148495 DOI: 10.1080/14737140.2019.1622417] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
61 Salminen A, Kauppinen A, Kaarniranta K. AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging. J Mol Med (Berl) 2019;97:1049-64. [PMID: 31129755 DOI: 10.1007/s00109-019-01795-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
62 Consonni FM, Porta C, Marino A, Pandolfo C, Mola S, Bleve A, Sica A. Myeloid-Derived Suppressor Cells: Ductile Targets in Disease. Front Immunol 2019;10:949. [PMID: 31130949 DOI: 10.3389/fimmu.2019.00949] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
63 Meng W, Hao Y, He C, Li L, Zhu G. Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer 2019;18:57. [PMID: 30925935 DOI: 10.1186/s12943-019-0982-6] [Cited by in Crossref: 96] [Cited by in F6Publishing: 107] [Article Influence: 24.0] [Reference Citation Analysis]
64 Boutouja F, Stiehm CM, Platta HW. mTOR: A Cellular Regulator Interface in Health and Disease. Cells 2019;8:E18. [PMID: 30609721 DOI: 10.3390/cells8010018] [Cited by in Crossref: 72] [Cited by in F6Publishing: 82] [Article Influence: 18.0] [Reference Citation Analysis]
65 Xu YJ, Chen FP, Chen Y, Fu B, Liu EY, Zou L, Liu LX. A Possible Reason to Induce Acute Graft-vs.-Host Disease After Hematopoietic Stem Cell Transplantation: Lack of Sirtuin-1 in CD4+ T Cells. Front Immunol 2018;9:3078. [PMID: 30622543 DOI: 10.3389/fimmu.2018.03078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
66 Lee YC, Su YT, Liu TY, Tsai CM, Chang CH, Yu HR. L-Arginine and L-Citrulline Supplementation Have Different Programming Effect on Regulatory T-Cells Function of Infantile Rats. Front Immunol 2018;9:2911. [PMID: 30619275 DOI: 10.3389/fimmu.2018.02911] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
67 Ohl K, Tenbrock K. Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression. Front Immunol 2018;9:2499. [PMID: 30425715 DOI: 10.3389/fimmu.2018.02499] [Cited by in Crossref: 153] [Cited by in F6Publishing: 163] [Article Influence: 30.6] [Reference Citation Analysis]
68 Liu J, Li Y, Lu Z, Gu J, Liang Y, Huang E, Wang Z, Zhang H, Wang L, Zhang D, Yu H, Liu R, Chu Y. Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1. Immunology 2019;156:56-68. [PMID: 30171602 DOI: 10.1111/imm.12998] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
69 Zhang B, Shi D, Zhang X, Liang G, Liu W, Qiao S. FK866 inhibits the epithelial-mesenchymal transition of hepatocarcinoma MHCC97-H cells. Oncol Lett. 2018;16:7231-7238. [PMID: 30546461 DOI: 10.3892/ol.2018.9541] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
70 Alissafi T, Hatzioannou A, Mintzas K, Barouni RM, Banos A, Sormendi S, Polyzos A, Xilouri M, Wielockx B, Gogas H, Verginis P. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest 2018;128:3840-52. [PMID: 29920188 DOI: 10.1172/JCI120888] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
71 Bryant AJ, Mehrad B, Brusko TM, West JD, Moldawer LL. Myeloid-Derived Suppressor Cells and Pulmonary Hypertension. Int J Mol Sci 2018;19:E2277. [PMID: 30081463 DOI: 10.3390/ijms19082277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
72 Yang F, Li Y, Zhang Q, Tan L, Peng L, Zhao Y. The Effect of Immunosuppressive Drugs on MDSCs in Transplantation. J Immunol Res 2018;2018:5414808. [PMID: 30057917 DOI: 10.1155/2018/5414808] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
73 Ma J, Xu H, Wang S. Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer. J Immunol Res 2018;2018:6319649. [PMID: 29765990 DOI: 10.1155/2018/6319649] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
74 Mohamed E, Al-Khami AA, Rodriguez PC. The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates. Cell Mol Immunol 2018;15:421-7. [PMID: 29568118 DOI: 10.1038/s41423-018-0001-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
75 Tcyganov E, Mastio J, Chen E, Gabrilovich DI. Plasticity of myeloid-derived suppressor cells in cancer. Curr Opin Immunol 2018;51:76-82. [PMID: 29547768 DOI: 10.1016/j.coi.2018.03.009] [Cited by in Crossref: 183] [Cited by in F6Publishing: 198] [Article Influence: 36.6] [Reference Citation Analysis]
76 Li L, Wang L, Li J, Fan Z, Yang L, Zhang Z, Zhang C, Yue D, Qin G, Zhang T, Li F, Chen X, Ping Y, Wang D, Gao Q, He Q, Huang L, Li H, Huang J, Zhao X, Xue W, Sun Z, Lu J, Yu JJ, Zhao J, Zhang B, Zhang Y. Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer. Cancer Res 2018;78:1779-91. [PMID: 29374065 DOI: 10.1158/0008-5472.CAN-17-2460] [Cited by in Crossref: 138] [Cited by in F6Publishing: 151] [Article Influence: 27.6] [Reference Citation Analysis]
77 Petrova V, Annicchiarico-Petruzzelli M, Melino G, Amelio I. The hypoxic tumour microenvironment. Oncogenesis. 2018;7:10. [PMID: 29362402 DOI: 10.1038/s41389-017-0011-9] [Cited by in Crossref: 480] [Cited by in F6Publishing: 497] [Article Influence: 96.0] [Reference Citation Analysis]
78 Yu L, Chen X, Wang L, Chen S. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget 2016;7:38908-26. [PMID: 26918353 DOI: 10.18632/oncotarget.7676] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 12.6] [Reference Citation Analysis]
79 Dorhoi A, Du Plessis N. Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections. Front Immunol 2017;8:1895. [PMID: 29354120 DOI: 10.3389/fimmu.2017.01895] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 16.4] [Reference Citation Analysis]
80 Yu L, Chen X, Sun X, Wang L, Chen S. The Glycolytic Switch in Tumors: How Many Players Are Involved? J Cancer 2017;8:3430-40. [PMID: 29151926 DOI: 10.7150/jca.21125] [Cited by in Crossref: 109] [Cited by in F6Publishing: 118] [Article Influence: 18.2] [Reference Citation Analysis]
81 Cai TT, Ye SB, Liu YN, He J, Chen QY, Mai HQ, Zhang CX, Cui J, Zhang XS, Busson P, Zeng YX, Li J. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma. PLoS Pathog 2017;13:e1006503. [PMID: 28732079 DOI: 10.1371/journal.ppat.1006503] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 12.2] [Reference Citation Analysis]
82 Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic Instruction of Immunity. Cell. 2017;169:570-586. [PMID: 28475890 DOI: 10.1016/j.cell.2017.04.004] [Cited by in Crossref: 642] [Cited by in F6Publishing: 665] [Article Influence: 107.0] [Reference Citation Analysis]
83 Al-Khami AA, Rodriguez PC, Ochoa AC. Energy metabolic pathways control the fate and function of myeloid immune cells. J Leukoc Biol 2017;102:369-80. [PMID: 28515225 DOI: 10.1189/jlb.1VMR1216-535R] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
84 Lu Y, Liu H, Bi Y, Yang H, Li Y, Wang J, Zhang Z, Wang Y, Li C, Jia A, Han L, Hu Y, Zhao Y, Wang R, Liu G. Glucocorticoid receptor promotes the function of myeloid-derived suppressor cells by suppressing HIF1α-dependent glycolysis. Cell Mol Immunol 2018;15:618-29. [PMID: 28287112 DOI: 10.1038/cmi.2017.5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
85 Wegner A, Verhagen J, Wraith DC. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease. Immunology 2017;151:26-42. [PMID: 28140447 DOI: 10.1111/imm.12718] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
86 Law AM, Lim E, Ormandy CJ, Gallego-Ortega D. The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. Endocr Relat Cancer 2017;24:R123-44. [PMID: 28193698 DOI: 10.1530/ERC-16-0404] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
87 Zimmermann A. Secondary Alterations of Hepatocellular Carcinoma. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_5] [Reference Citation Analysis]
88 Jayashankar L, Hafner R. Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination. Front Immunol 2016;7:577. [PMID: 28018344 DOI: 10.3389/fimmu.2016.00577] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
89 Pergamo M, Miller G. Myeloid-derived suppressor cells and their role in pancreatic cancer. Cancer Gene Ther 2017;24:100-5. [PMID: 27910857 DOI: 10.1038/cgt.2016.65] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
90 He W, Liang P, Guo G, Huang Z, Niu Y, Dong L, Wang C, Zhang J. Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy. Sci Rep 2016;6:24506. [PMID: 27074905 DOI: 10.1038/srep24506] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
91 De Vlaeminck Y, González-Rascón A, Goyvaerts C, Breckpot K. Cancer-Associated Myeloid Regulatory Cells. Front Immunol 2016;7:113. [PMID: 27065074 DOI: 10.3389/fimmu.2016.00113] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
92 Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends Immunol 2016;37:208-20. [PMID: 26858199 DOI: 10.1016/j.it.2016.01.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends Immunol. 2016;37:208-220. [PMID: 26858199 DOI: 10.1016/j.it.2016.01.004] [Cited by in Crossref: 1107] [Cited by in F6Publishing: 981] [Article Influence: 158.1] [Reference Citation Analysis]
94 Riboldi E, Sica A. Modulation of Innate Immunity by Hypoxia. The Innate Immune Response to Noninfectious Stressors 2016. [DOI: 10.1016/b978-0-12-801968-9.00004-0] [Reference Citation Analysis]
95 Zimmermann A. Secondary Alterations of Hepatocellular Carcinoma. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_5-1] [Reference Citation Analysis]
96 Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol 2016;12:169-82. [PMID: 26698023 DOI: 10.1038/nrrheum.2015.172] [Cited by in Crossref: 186] [Cited by in F6Publishing: 200] [Article Influence: 23.3] [Reference Citation Analysis]
97 O'Connor MA, Vella JL, Green WR. Reciprocal relationship of T regulatory cells and monocytic myeloid-derived suppressor cells in LP-BM5 murine retrovirus-induced immunodeficiency. J Gen Virol 2016;97:509-22. [PMID: 26253145 DOI: 10.1099/jgv.0.000260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
98 Chen X, Lu Y, Zhang Z, Wang J, Yang H, Liu G. Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology. Immunology 2015;145:455-67. [PMID: 25890999 DOI: 10.1111/imm.12473] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
99 Perl A. mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci 2015;1346:33-44. [PMID: 25907074 DOI: 10.1111/nyas.12756] [Cited by in Crossref: 148] [Cited by in F6Publishing: 160] [Article Influence: 18.5] [Reference Citation Analysis]
100 Liu G, Bi Y, Xue L, Zhang Y, Yang H, Chen X, Lu Y, Zhang Z, Liu H, Wang X, Wang R, Chu Y, Yang R. Dendritic cell SIRT1-HIF1α axis programs the differentiation of CD4+ T cells through IL-12 and TGF-β1. Proc Natl Acad Sci U S A 2015;112:E957-65. [PMID: 25730867 DOI: 10.1073/pnas.1420419112] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 9.9] [Reference Citation Analysis]
101 Kumar V, Gabrilovich DI. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment. Immunology 2014;143:512-9. [PMID: 25196648 DOI: 10.1111/imm.12380] [Cited by in Crossref: 199] [Cited by in F6Publishing: 217] [Article Influence: 24.9] [Reference Citation Analysis]
102 Eisenstein S, Chen SH, Pan PY. Immune cells: more than simple carriers for systemic delivery of oncolytic viruses. Oncolytic Virother 2014;3:83-91. [PMID: 25767789 DOI: 10.2147/OV.S47143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
103 Wang T, Liu G, Wang R. The Intercellular Metabolic Interplay between Tumor and Immune Cells. Front Immunol 2014;5:358. [PMID: 25120544 DOI: 10.3389/fimmu.2014.00358] [Cited by in Crossref: 45] [Cited by in F6Publishing: 58] [Article Influence: 5.0] [Reference Citation Analysis]